President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are ...
Hosted on MSN
Zevra signals European expansion for MIPLYFFA as U.S. coverage reaches 66% following robust Q3
CEO Neil McFarlane highlighted continued momentum for Zevra in Q3, emphasizing "the strong performance of MIPLYFFA, which is delivering meaningful benefits to patients with Niemann-Pick disease type C ...
WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy ...
WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback